Chinese Anti-Cancer Association

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

Junjie Li, Ke‐Da Yu, Da Pang et al. · Journal of Clinical Oncology · 2020 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification

Hai‐Qiang Mai, Wai Tong Ng, Chaosu Hu et al. · JAMA Oncology · 2024 · 102 citations · Full text

Medicine, Oncology, Surgery +17

Cost-effectiveness analysis of pembrolizumab monotherapy and chemotherapy in the non-small-cell lung cancer with different PD-L1 tumor proportion scores

Kexun Zhou, Chenlu Jiang, Qiu Li · Lung Cancer · 2019 · 56 citations

Medicine, Oncology, Pharmacology +16

Probability of cancer in high‐risk patients predicted by the protein‐based lung cancer biomarker panel in China: <scp>LCBP</scp> study

Dawei Yang, Xiaoju Zhang, Charles A. Powell et al. · Cancer · 2017 · 55 citations · Full text

Medicine, Oncology, Cancer Screening +16

Preliminary effectiveness of breast cancer screening among 1.22 million Chinese females and different cancer patterns between urban and rural women

Yubei Huang, Fengju Song, Haixin Li et al. · Scientific Reports · 2016 · 48 citations · Full text

Medicine, Oncology, Preventive Medicine +11